menu

Slide

Investments in unique diagnostic technologies for the era of precision medicine

Scroll Down
Scroll Down
NeuroKaire Closes $10M Funding Round 

READ MORE

NeuroKaire Receives Clinical Laboratory Improvement Amendments Certification 

READ MORE

GEHA MENTAL HEALTH CENTER AND GENETIKA+ PARTNER ON NOVEL SOLUTIONS DRIVING PRECISION MEDICINE IN DEPRESSION

READ MORE

NeuroSense and Genetika+ Initiate Precision Medicine Collaboration Beginning with Ongoing Phase 2 Clinical Trial in Alzheimer’s Disease

READ MORE

GreyBird Ventures

is named after the arctic tern, a bird that migrates 71,000 km annually. As they can live for 30 years, this is the lifetime equivalent of three trips to the moon and back. Not bad for a 100 gram bird. We strive to emulate its size to performance ratio as well as its global reach.

MEET THE PEOPLE

For additional information, please contact: greybird@greybirdventures.com

DISCLAIMER